Boston Scientific Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 1,216.0 | 934.0 | 1,845.0 |
| Net Investing Cash Flow | 324.0 | (474.0) | (9,312.0) |
| Net Financing Cash Flow | (1,350.0) | (680.0) | 8,439.0 |
| Net Change in Cash | 189.0 | (216.0) | 979.0 |
| Depreciation & Amortization | 543.0 | 641.0 | 530.0 |
| Capital Expenditures | (362.0) | (363.0) | (341.0) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
